Chirag Sachar

Chirag graduated from UChicago in 2016, studying Biology and Molecular Engineering, and went straight to the MS/Ph.D. program at Columbia University, studying Biomedical Engineering. His research focused on engineering the immune system to improve immunotherapies. He now supports business development and alliance management at Immunai, an Israeli biotech startup where he focuses on leveraging Immunai's machine learning platform to support Pharma drug development in the cancer and autoimmunity spaces.